The drug, Keytruda, is the first approved for patients with tumors with a particular genetic signature, wherever they appear in the body.
Published: June 8, 2017 at 02:00AM
from NYT Health https://ift.tt/2sYhsYA
The drug, Keytruda, is the first approved for patients with tumors with a particular genetic signature, wherever they appear in the body.
Published: June 8, 2017 at 02:00AM
from NYT Health https://ift.tt/2sYhsYA